What considerations should we give to adynamic bone disease?

被引：5

作者：

Couttenye, MM ^{[1
]}

D'Haese, PC ^{[1
]}

De Broe, ME ^{[1
]}

机构：

[1] Univ Antwerp, Dept Nephrol Hypertens, B-2020 Antwerp, Belgium

来源：

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 1998年 / 21卷 / 11期

关键词：

D O I：

10.1177/039139889802101102

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

引用

页码：687 / 692

页数：6

共 47 条

[1] IDENTIFICATION OF A LOW-MOLECULAR-WEIGHT INHIBITOR OF OSTEOBLAST MITOGENESIS IN UREMIC PLASMA [J].

ANDRESS, DL ;

HOWARD, GA ;

BIRNBAUM, RS .

KIDNEY INTERNATIONAL, 1991, 39 (05) :942-945

[2] CALCIUM KINETICS AND THE LONG-TERM EFFECTS OF LOWERING DIALYSATE CALCIUM-CONCENTRATION [J].

ARGILES, A ;

KERR, PG ;

CANAUD, B ;

FLAVIER, JL ;

MION, C .

KIDNEY INTERNATIONAL, 1993, 43 (03) :630-640

[3] IMPAIRED OSTEOBLAST FUNCTION IN OSTEOPOROSIS - COMPARISON BETWEEN CALCIUM BALANCE AND DYNAMIC HISTOMORPHOMETRY [J].

ARLOT, M ;

EDOUARD, C ;

MEUNIER, PJ ;

NEER, RM ;

REEVE, J .

BRITISH MEDICAL JOURNAL, 1984, 289 (6444) :517-520

[4]

BURRITT MF, 1980, MAYO CLIN PROC, V55, P606

[5]

COBURN W, 1993, KIDNEY INT S, V43, pS92

[6] NON-ALUMINIC ADYNAMIC BONE-DISEASE IN NON-DIALYZED UREMIC PATIENTS - A NEW TYPE OF OSTEOPATHY DUE TO OVERTREATMENT [J].

COHENSOLAL, ME ;

SEBERT, JL ;

BOUDAILLIEZ, B ;

WESTEEL, PF ;

MORINIERE, PH ;

MARIE, A ;

GARABEDIAN, M ;

FOURNIER, A .

BONE, 1992, 13 (01) :1-5

[7] High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population [J].

Couttenye, MM ;

DHaese, PC ;

Deng, JT ;

VanHoof, VO ;

Verpooten, GA ;

DeBroe, ME .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (10) :2144-2150

[8]

Couttenye MM, 1996, NEPHROL DIAL TRANSPL, V11, P1065

[9]

COUTTENYE MM, 1997, THESIS, P123

[10]

Delmas PD, 1992, BONE, P17

← 1 2 3 4 5 →